MX2024006730A - Recubrimiento biomimetico para endoprotesis vascular - Google Patents

Recubrimiento biomimetico para endoprotesis vascular

Info

Publication number
MX2024006730A
MX2024006730A MX2024006730A MX2024006730A MX2024006730A MX 2024006730 A MX2024006730 A MX 2024006730A MX 2024006730 A MX2024006730 A MX 2024006730A MX 2024006730 A MX2024006730 A MX 2024006730A MX 2024006730 A MX2024006730 A MX 2024006730A
Authority
MX
Mexico
Prior art keywords
peptides
homophilic
leukocytes
trans
engagement
Prior art date
Application number
MX2024006730A
Other languages
English (en)
Spanish (es)
Inventor
Giuseppina Caligiuri
Antonino Nicoletti
Charles Skarbek
Isabelle Lefevre
Christophe Bureau
Original Assignee
Inst Nat Sante Rech Med
Univ Paris Cite
Univ Paris Xiii Paris Nord
Alchimedics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Univ Paris Cite, Univ Paris Xiii Paris Nord, Alchimedics filed Critical Inst Nat Sante Rech Med
Publication of MX2024006730A publication Critical patent/MX2024006730A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/18—Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Prostheses (AREA)
MX2024006730A 2021-12-03 2024-05-31 Recubrimiento biomimetico para endoprotesis vascular MX2024006730A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2021/000860 WO2023099932A1 (en) 2021-12-03 2021-12-03 Cd31 mimetic coating for endovascular stent
PCT/IB2022/000684 WO2023099957A2 (en) 2021-12-03 2022-12-02 Biomimetic coating for endovascular stent

Publications (1)

Publication Number Publication Date
MX2024006730A true MX2024006730A (es) 2024-11-08

Family

ID=79601491

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024006730A MX2024006730A (es) 2021-12-03 2024-05-31 Recubrimiento biomimetico para endoprotesis vascular

Country Status (10)

Country Link
US (2) US20250281679A1 (enExample)
EP (2) EP4440643A2 (enExample)
JP (2) JP2024542779A (enExample)
KR (2) KR20240155852A (enExample)
CN (2) CN118843485A (enExample)
AU (1) AU2022402537A1 (enExample)
CA (1) CA3241253A1 (enExample)
IL (1) IL313268A (enExample)
MX (1) MX2024006730A (enExample)
WO (3) WO2023099932A1 (enExample)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2294321A (en) * 1994-10-19 1996-04-24 Yamanouchi Research Inst Method of screening for CD31 interaction inhibitors
JP2011526485A (ja) * 2008-06-30 2011-10-13 アンスティテュ、ナショナル、ド、ラ、サント、エ、ド、ラ、ルシェルシュ、メディカル（アンセルム） 血栓障害および自己免疫障害の処置におけるｃｄ３１ペプチドの使用
SI2861241T1 (sl) * 2012-06-19 2021-11-30 Institut National De La Sante Et De La Recherche Medicale (Inserm) Izboljšani CD31 peptidi
CA3059800A1 (en) 2017-04-13 2018-10-18 Orbusneich Medical Pte. Ltd. Medical devices coated with polydopamine and antibodies
US20220001083A1 (en) 2018-11-27 2022-01-06 Balt Extrusion Method for the modification of a device surface by grafting a cd31-derived peptide onto the surface of said device
WO2020109833A1 (en) * 2018-11-27 2020-06-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for the modification of a substrate surface by grafting a peptide onto the surface of said substrate
EP4157282A1 (en) 2020-05-28 2023-04-05 Institut National de la Santé et de la Recherche Médicale (INSERM) Compounds for the prevention, treatment and diagnosis of thrombi

Also Published As

Publication number Publication date
CA3241253A1 (en) 2023-06-08
WO2023099748A2 (en) 2023-06-08
WO2023099932A1 (en) 2023-06-08
US20250381324A1 (en) 2025-12-18
KR20240155852A (ko) 2024-10-29
WO2023099957A3 (en) 2023-07-13
EP4440643A2 (en) 2024-10-09
CN118475376A (zh) 2024-08-09
WO2023099748A3 (en) 2023-07-13
CN118843485A (zh) 2024-10-25
IL313268A (en) 2024-08-01
WO2023099957A2 (en) 2023-06-08
EP4440644A2 (en) 2024-10-09
JP2024542779A (ja) 2024-11-15
KR20240155186A (ko) 2024-10-28
JP2024542778A (ja) 2024-11-15
US20250281679A1 (en) 2025-09-11
AU2022402537A1 (en) 2024-07-11

Similar Documents

Publication Publication Date Title
Esmon Basic mechanisms and pathogenesis of venous thrombosis
Esquivel et al. Why small caliber vascular grafts fail: a review of clinical and experimental experience and the significance of the interaction of blood at the interface
Periayah et al. Mechanism action of platelets and crucial blood coagulation pathways in hemostasis
Swieringa et al. Integrating platelet and coagulation activation in fibrin clot formation
Ghorashian et al. “Off-license” use of recombinant activated factor VII
Sørensen et al. Fibrinogen as a hemostatic agent
Cho et al. Role of fibronectin assembly in platelet thrombus formation
Cardenas et al. Mechanisms of trauma-induced coagulopathy
Tubek et al. Role of zinc in hemostasis: a review
Skrzypchak et al. Effect of varying nitric oxide release to prevent platelet consumption and preserve platelet function in an in vivo model of extracorporeal circulation
Gertler et al. Hypoxia induces procoagulant activity in cultured human venous endothelium
Valeanu et al. Blood rheology alterations in patients with cardiovascular diseases
Gertler et al. Prothrombotic and fibrinolytic function of normal and perturbed endothelium
Uyar et al. Alpha lipoic acid attenuates inflammatory response during extracorporeal circulation
Podesser et al. Nitric oxide homeostasis as a target for drug additives to cardioplegia
WO2023099957A3 (en) Medical device with cd31 mimetic coating
Maroney et al. Platelet tissue factor pathway inhibitor modulates intravascular coagulation
Kennedy Attenuating a sickle cell crisis with annexin V
Harpel Homocysteine, atherogenesis and thrombosis
Gurkan et al. The effect of distension pressure on endothelial injury and vasodilatation response in saphenous vein grafts: conversion of a bypass graft to a dead pipe
McCarron et al. Agonist-stimulated release of von Willebrand factor and procoagulant factor VIII in rats with and without risk factors for stroke
Furlan Sticky and promiscuous plasma proteins maintain the equilibrium between bleeding and thrombosis
Guzmán et al. Simultaneous stimulation of fatty acid synthesis and oxidation in rat hepatocytes by vanadate
Huet et al. Bivalirudin is inferior to heparin in preservation of intraoperative autologous blood
Skubas et al. Optimal management of bleeding complications after cardiac surgery